SEVOFLURANE

SEVOFLURANE was reported 8432 times

SEVOFLURANE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DELFTIA ACIDOVORANS INFECTION 3 0.7500
1 CONGENITAL CLAVICULAR AGENESIS 7 0.5833
2 ANAESTHETIC COMPLICATION NEUROLOGICAL 522 0.5762
3 OCULOCARDIAC REFLEX 9 0.5625
4 BONE CEMENT IMPLANTATION SYNDROME 4 0.5000
5 LIGHT ANAESTHESIA 5 0.4545
6 END-TIDAL CO2 INCREASED 20 0.4348
7 NEGATIVE PRESSURE PULMONARY OEDEMA 42 0.4286
8 EPILEPSY WITH MYOCLONIC-ATONIC SEIZURES 11 0.3929
9 UNWANTED AWARENESS DURING ANAESTHESIA 94 0.2866
10 MYOGLOBIN URINE PRESENT 66 0.2683
11 TRACHEAL DEVIATION 23 0.2614
12 ICTAL BRADYCARDIA SYNDROME 4 0.2500
13 BISPECTRAL INDEX DECREASED 3 0.2500
14 RECURRENCE OF NEUROMUSCULAR BLOCKADE 41 0.2398
15 MITOCHONDRIAL ENZYME DEFICIENCY 11 0.2292
16 DELAYED RECOVERY FROM ANAESTHESIA 197 0.2078
17 OCCUPATIONAL EXPOSURE TO DRUG 7 0.2059
18 HYPERTHERMIA MALIGNANT 299 0.2008
19 AIRWAY PEAK PRESSURE INCREASED 26 0.1711
20 NEUROMUSCULAR BLOCK PROLONGED 63 0.1707
21 TIDAL VOLUME DECREASED 6 0.1538
22 END-TIDAL CO2 DECREASED 7 0.1489
23 CENTRAL VENOUS PRESSURE DECREASED 5 0.1429
24 BASAL GANGLION DEGENERATION 13 0.1383
25 ANAESTHETIC COMPLICATION CARDIAC 9 0.1304
26 AGITATION POSTOPERATIVE 8 0.1270
27 CHEST WALL RIGIDITY 8 0.1250
28 ANAESTHETIC COMPLICATION PULMONARY 11 0.1236
29 POSTOPERATIVE DELIRIUM 23 0.1162
30 EXCESSIVE DYNAMIC AIRWAY COLLAPSE 3 0.1154
31 PHRENIC NERVE PARALYSIS 25 0.1142
32 TRIGEMINO-CARDIAC REFLEX 9 0.1111
33 NON-OBSTRUCTIVE CARDIOMYOPATHY 4 0.1111
34 POSTOPERATIVE RESPIRATORY DISTRESS 7 0.1094
35 NEUROMUSCULAR BLOCKADE 24 0.1071
36 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 7 0.0933
37 PROCEDURAL HYPERTENSION 17 0.0904
38 FLUOROSIS 7 0.0814
39 TRYPTASE DECREASED 4 0.0784
40 FIBRINOLYSIS 5 0.0735
41 CARCINOID CRISIS 16 0.0708
42 AIRWAY COMPLICATION OF ANAESTHESIA 18 0.0684
43 MYOTONIA 15 0.0676
44 APGAR SCORE ABNORMAL 7 0.0660
45 PSEUDOCHOLINESTERASE DEFICIENCY 4 0.0615
46 ACCELERATED IDIOVENTRICULAR RHYTHM 9 0.0608
47 MITOCHONDRIAL ENCEPHALOMYOPATHY 4 0.0563
48 AUTONOMIC DYSREFLEXIA 9 0.0556
49 ANAESTHETIC COMPLICATION 148 0.0551
50 GLOSSOPTOSIS 12 0.0548
51 CARDIAC VALVE ABSCESS 5 0.0538
52 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 4 0.0476
53 MECHANICAL VENTILATION COMPLICATION 7 0.0470
54 CHEMICAL PERITONITIS 9 0.0455
55 LONG QT SYNDROME CONGENITAL 4 0.0444
56 LARYNGEAL OBSTRUCTION 8 0.0437
57 POST PROCEDURAL STROKE 8 0.0435
58 ATRIOVENTRICULAR BLOCK THIRD DEGREE 4 0.0417
59 HARLEQUIN SYNDROME 3 0.0411
60 NEPHROGENIC DIABETES INSIPIDUS 46 0.0399
61 SODIUM RETENTION 8 0.0392
62 SPINAL CORD INFARCTION 17 0.0385
63 OPERATIVE HAEMORRHAGE 17 0.0380
64 DIABETES INSIPIDUS 89 0.0369
65 HYPERDYNAMIC LEFT VENTRICLE 9 0.0366
66 PCO2 INCREASED 26 0.0365
67 NEONATAL RESPIRATORY DEPRESSION 12 0.0361
68 PROCEDURAL HYPOTENSION 30 0.0353
69 CHOROIDAL INFARCTION 4 0.0333
70 ALLERGY TEST NEGATIVE 5 0.0321
71 MEAN ARTERIAL PRESSURE DECREASED 8 0.0316
72 CHANTER SYNDROME 3 0.0300
73 STATUS ASTHMATICUS 14 0.0297
74 RENIN INCREASED 8 0.0293
75 BASAL GANGLIA INFARCTION 10 0.0291
76 ENDOTRACHEAL INTUBATION COMPLICATION 17 0.0288
77 BLOOD PRESSURE MEASUREMENT 18 0.0280
78 SICK LEAVE 6 0.0267
79 SPINAL CORD ISCHAEMIA 4 0.0263
80 LARYNGOSPASM 70 0.0260
81 HYPERCAPNIA 76 0.0252
82 VENTRICULAR TACHYARRHYTHMIA 8 0.0251
83 HYPEROSMOLAR STATE 7 0.0243
84 MATERNAL EXPOSURE DURING DELIVERY 23 0.0232
85 MYXOEDEMA COMA 7 0.0230
86 BRADYCARDIA FOETAL 19 0.0229
87 OXYGEN SATURATION 6 0.0228
88 HYPOXIC ENCEPHALOPATHY 9 0.0220
89 VASOPLEGIA SYNDROME 36 0.0219
90 PAROTID GLAND ENLARGEMENT 13 0.0199
91 LUNG HYPERINFLATION 17 0.0198
92 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 43 0.0196
93 COMPLICATIONS OF TRANSPLANTED LIVER 7 0.0194
94 HEAD CIRCUMFERENCE ABNORMAL 3 0.0194
95 HYPOCAPNIA 8 0.0191
96 PO2 DECREASED 22 0.0191
97 LIMB REDUCTION DEFECT 11 0.0188
98 MYOGLOBINURIA 10 0.0188
99 ATRIOVENTRICULAR DISSOCIATION 4 0.0187
100 HOLOPROSENCEPHALY 3 0.0186
101 PULMONARY HYPERTENSIVE CRISIS 5 0.0185
102 CARDIAC OUTPUT DECREASED 16 0.0181
103 DRUG EFFECT PROLONGED 10 0.0181
104 PULMONARY ALVEOLAR HAEMORRHAGE 101 0.0180
105 TRACHEOMALACIA 7 0.0177
106 AMYLASE INCREASED 64 0.0173
107 CHANGE IN SEIZURE PRESENTATION 11 0.0170
108 SINUS ARREST 26 0.0166
109 RESPIRATORY ACIDOSIS 64 0.0163
110 PROCEDURAL NAUSEA 13 0.0161
111 UPPER AIRWAY OBSTRUCTION 14 0.0158
112 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 50 0.0151
113 KOUNIS SYNDROME 34 0.0150
114 BRAIN STEM SYNDROME 11 0.0147
115 MACROGLOSSIA 8 0.0145
116 GASTROINTESTINAL ISCHAEMIA 4 0.0144
117 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 3 0.0144
118 PROPOFOL INFUSION SYNDROME 10 0.0142
119 APNOEIC ATTACK 8 0.0142
120 HYPOVENTILATION 46 0.0141
121 TOXIC ENCEPHALOPATHY 71 0.0140
122 VENTRICULAR FIBRILLATION 155 0.0139
123 STRESS CARDIOMYOPATHY 81 0.0139
124 PROCEDURAL VOMITING 9 0.0138
125 ELECTROMECHANICAL DISSOCIATION 11 0.0138
126 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 36 0.0137
127 HAEMODYNAMIC INSTABILITY 104 0.0136
128 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
129 ARTICULAR CALCIFICATION 3 0.0134
130 NON-CARDIOGENIC PULMONARY OEDEMA 14 0.0132
131 SEROTONIN SYNDROME 252 0.0131
132 CARDIAC PERFORATION 3 0.0130
133 FOETAL HEART RATE DECELERATION 3 0.0129
134 BLOOD PH DECREASED 22 0.0129
135 BRONCHOSPASM 182 0.0127
136 DEVICE INTERACTION 3 0.0127
137 AGNOSIA 3 0.0126
138 TRYPTASE INCREASED 9 0.0126
139 HYPERTHERMIA 96 0.0126
140 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 4 0.0125
141 SUBCUTANEOUS EMPHYSEMA 12 0.0122
142 ARTERIOSPASM CORONARY 49 0.0122
143 PNEUMOCEPHALUS 4 0.0121
144 PRINZMETAL ANGINA 12 0.0121
145 TRACHEAL STENOSIS 6 0.0118
146 SEIZURE LIKE PHENOMENA 20 0.0118
147 LOW BIRTH WEIGHT BABY 92 0.0116
148 CIRCUMORAL OEDEMA 4 0.0115
149 TORSADE DE POINTES 90 0.0115
150 EPIGLOTTIC OEDEMA 3 0.0114
151 APNOEA 88 0.0113
152 NEONATAL ASPHYXIA 8 0.0113
153 SYMPTOM MASKED 8 0.0110
154 RIGHT VENTRICULAR DYSFUNCTION 12 0.0109
155 STRIDOR 32 0.0109
156 PSYCHOGENIC SEIZURE 10 0.0107
157 BRUGADA SYNDROME 11 0.0106
158 AIR EMBOLISM 5 0.0106
159 PUPILS UNEQUAL 12 0.0105
160 LONG QT SYNDROME 25 0.0104
161 BREATH HOLDING 4 0.0104
162 CARDIAC VALVE VEGETATION 5 0.0103
163 NODAL RHYTHM 15 0.0102
164 ANAPHYLACTIC SHOCK 263 0.0102
165 SPINAL EPIDURAL HAEMATOMA 6 0.0102
166 ACIDOSIS HYPERCHLORAEMIC 6 0.0101
167 SENSORIMOTOR DISORDER 5 0.0101
168 ELECTROCARDIOGRAM T WAVE PEAKED 4 0.0100
169 CARBON DIOXIDE INCREASED 13 0.0095
170 TROPONIN INCREASED 71 0.0093
171 BLOOD GASES ABNORMAL 5 0.0093
172 SYSTOLIC HYPERTENSION 4 0.0092
173 COAGULATION FACTOR V LEVEL DECREASED 3 0.0092
174 VENTRICULAR TACHYCARDIA 149 0.0090
175 POSTOPERATIVE ILEUS 5 0.0089
176 PROCEDURAL COMPLICATION 68 0.0089
177 FOETAL EXPOSURE DURING DELIVERY 6 0.0088
178 THERAPEUTIC PRODUCT EFFECT PROLONGED 4 0.0088
179 RESPIRATORY DEPRESSION 108 0.0088
180 ATRIOVENTRICULAR BLOCK SECOND DEGREE 26 0.0086
181 PSEUDOMONAL SEPSIS 15 0.0086
182 FOETAL HEART RATE DECELERATION ABNORMALITY 6 0.0085
183 BLOOD BICARBONATE DECREASED 16 0.0084
184 SYNDACTYLY 7 0.0084
185 THYROID CYST 5 0.0084
186 DISSOCIATIVE DISORDER 6 0.0083
187 CARDIAC DEATH 10 0.0083
188 CONVERSION DISORDER 16 0.0082
189 OROMANDIBULAR DYSTONIA 6 0.0082
190 CLONIC CONVULSION 6 0.0082
191 ANTICHOLINERGIC SYNDROME 13 0.0082
192 OPEN ANGLE GLAUCOMA 5 0.0081
193 EOSINOPHILIC PNEUMONIA ACUTE 7 0.0081
194 COMPARTMENT SYNDROME 21 0.0080
195 FOETAL HEART RATE DECREASED 5 0.0080
196 PULSE ABSENT 37 0.0078
197 APGAR SCORE LOW 10 0.0078
198 HYPERNATRAEMIA 38 0.0076
199 ACUTE LUNG INJURY 9 0.0076
200 GENITAL ABSCESS 3 0.0074
201 WEIGHT BEARING DIFFICULTY 20 0.0074
202 CARDIOVASCULAR INSUFFICIENCY 12 0.0074
203 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 6 0.0074
204 BRADYCARDIA 381 0.0072
205 MYOCARDIAL INJURY 8 0.0071
206 EYE ROLLING 5 0.0071
207 NODAL ARRHYTHMIA 6 0.0070
208 SICK SINUS SYNDROME 8 0.0070
209 PULSELESS ELECTRICAL ACTIVITY 29 0.0069
210 EXTRASYSTOLES 48 0.0069
211 RESPIRATORY TRACT HAEMORRHAGE 4 0.0067
212 DIAPHRAGMATIC PARALYSIS 4 0.0067
213 ACIDOSIS 51 0.0067
214 RESUSCITATION 11 0.0066
215 BLOOD PRESSURE IMMEASURABLE 10 0.0065
216 OCULOGYRIC CRISIS 14 0.0065
217 CEREBRAL HYPOPERFUSION 3 0.0064
218 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 7 0.0064
219 GASTROSCHISIS 3 0.0063
220 BLOOD LACTIC ACID INCREASED 33 0.0063
221 CYANOSIS NEONATAL 4 0.0062
222 ACUTE PULMONARY OEDEMA 35 0.0062
223 PCO2 DECREASED 6 0.0062
224 RESPIRATORY ALKALOSIS 10 0.0061
225 PHAEOCHROMOCYTOMA 4 0.0061
226 DYSCHROMATOPSIA 5 0.0060
227 AMAUROSIS 5 0.0059
228 POSTPARTUM HAEMORRHAGE 8 0.0059
229 MYOGLOBIN BLOOD INCREASED 9 0.0059
230 SEDATION COMPLICATION 15 0.0059
231 HEPATITIS FULMINANT 17 0.0057
232 FOETAL HYPOKINESIA 4 0.0057
233 VENTRICULAR EXTRASYSTOLES 59 0.0057
234 HYPERMETABOLISM 3 0.0057
235 PROCEDURAL HAEMORRHAGE 22 0.0056
236 TONGUE PARALYSIS 4 0.0056
237 VENTRICULAR HYPOKINESIA 18 0.0056
238 PARAPLEGIA 16 0.0055
239 RIGHT VENTRICULAR HYPERTROPHY 5 0.0055
240 BRAIN DEATH 17 0.0055
241 MUSCLE RIGIDITY 65 0.0054
242 QUADRIPARESIS 9 0.0054
243 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
244 SKIN TEST POSITIVE 5 0.0054
245 BUNDLE BRANCH BLOCK 5 0.0053
246 THYROTOXIC CRISIS 6 0.0053
247 TRISMUS 27 0.0052
248 DIFFUSE ALVEOLAR DAMAGE 6 0.0052
249 CARDIAC ARREST 430 0.0052
250 PUPIL FIXED 9 0.0052
251 COMA SCALE ABNORMAL 15 0.0052
252 COAGULATION TIME PROLONGED 8 0.0052
253 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 4 0.0051
254 APPENDICITIS PERFORATED 13 0.0051
255 METAPNEUMOVIRUS INFECTION 4 0.0051
256 BLOOD POTASSIUM INCREASED 82 0.0050
257 OPISTHOTONUS 4 0.0050
258 GRUNTING 3 0.0050
259 TACHYPNOEA 68 0.0050
260 ENDOTRACHEAL INTUBATION 14 0.0050
261 PERFORMANCE STATUS DECREASED 23 0.0049
262 NYSTAGMUS 26 0.0049
263 POST PROCEDURAL COMPLICATION 94 0.0049
264 AREFLEXIA 13 0.0049
265 BLOOD LACTATE DEHYDROGENASE INCREASED 77 0.0049
266 HYPOXIA 170 0.0048
267 MUTISM 7 0.0048
268 SUPRAVENTRICULAR EXTRASYSTOLES 16 0.0047
269 TORTICOLLIS 10 0.0047
270 ABDOMINAL COMPARTMENT SYNDROME 3 0.0047
271 DYSTONIA 91 0.0047
272 BRAIN HERNIATION 14 0.0047
273 STUPOR 15 0.0047
274 RHABDOMYOLYSIS 194 0.0046
275 BLOOD PRESSURE SYSTOLIC DECREASED 21 0.0046
276 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
277 HYPERVENTILATION 26 0.0045
278 TRANSPLANT DYSFUNCTION 8 0.0045
279 CIRCULATORY COLLAPSE 76 0.0045
280 PERIORBITAL OEDEMA 23 0.0044
281 MIGRAINE WITH AURA 12 0.0044
282 ATRIOVENTRICULAR BLOCK 34 0.0044
283 CLONUS 12 0.0044
284 VENTRICULAR ARRHYTHMIA 16 0.0044
285 ANAPHYLACTOID REACTION 18 0.0044
286 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
287 ANASTOMOTIC LEAK 3 0.0043
288 HYPOPNOEA 15 0.0043
289 NEUROLOGICAL DECOMPENSATION 10 0.0043
290 INCREASED BRONCHIAL SECRETION 11 0.0043
291 PULMONARY ARTERIAL PRESSURE INCREASED 7 0.0043
292 ANAPHYLACTIC REACTION 237 0.0043
293 RESTRICTIVE PULMONARY DISEASE 5 0.0043
294 PROCALCITONIN INCREASED 5 0.0043
295 BRADYARRHYTHMIA 7 0.0043
296 HEPATIC NECROSIS 16 0.0042
297 SINUS TACHYCARDIA 60 0.0042
298 LANGUAGE DISORDER 9 0.0042
299 METABOLIC ACIDOSIS 133 0.0042
300 GAZE PALSY 7 0.0041
301 CEREBRAL ARTERY EMBOLISM 5 0.0041
302 BLOOD CREATINE PHOSPHOKINASE INCREASED 117 0.0041
303 GENERALISED ERYTHEMA 23 0.0040
304 OXYGEN SATURATION DECREASED 226 0.0040
305 HYPERREFLEXIA 14 0.0040
306 HEART SOUNDS ABNORMAL 3 0.0040
307 FOOD INTERACTION 7 0.0040
308 VASODILATATION 10 0.0040
309 CYANOSIS 62 0.0039
310 ANGLE CLOSURE GLAUCOMA 10 0.0039
311 CAUDA EQUINA SYNDROME 3 0.0039
312 POLYURIA 32 0.0039
313 VOCAL CORD PARALYSIS 7 0.0039
314 COAGULATION TEST ABNORMAL 3 0.0039
315 ADENOCARCINOMA PANCREAS 5 0.0039
316 VENTRICULAR DYSFUNCTION 10 0.0039
317 ANURIA 33 0.0038
318 URINARY BLADDER HAEMORRHAGE 8 0.0038
319 EXTRADURAL HAEMATOMA 5 0.0038
320 PUPILLARY REFLEX IMPAIRED 7 0.0038
321 INTESTINAL DILATATION 5 0.0037
322 OCCUPATIONAL EXPOSURE TO PRODUCT 24 0.0037
323 LARYNGEAL OEDEMA 23 0.0037
324 HYPERLACTACIDAEMIA 10 0.0037
325 IIIRD NERVE PARALYSIS 3 0.0037
326 MUSCLE CONTRACTIONS INVOLUNTARY 13 0.0037
327 MECHANICAL VENTILATION 7 0.0037
328 HAEMORRHAGIC DISORDER 4 0.0037
329 MYDRIASIS 47 0.0037
330 ARRHYTHMIA SUPRAVENTRICULAR 4 0.0037
331 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
332 COLLAPSE OF LUNG 3 0.0036
333 DIPLEGIA 7 0.0035
334 RESPIRATORY RATE DECREASED 11 0.0035
335 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 27 0.0035
336 CARBON DIOXIDE DECREASED 4 0.0035
337 CORONARY ARTERY THROMBOSIS 7 0.0035
338 PAROTITIS 4 0.0034
339 STRABISMUS 10 0.0034
340 LABILE BLOOD PRESSURE 4 0.0034
341 BILE DUCT CANCER 4 0.0034
342 LIVEDO RETICULARIS 7 0.0033
343 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
344 HYPOVOLAEMIC SHOCK 16 0.0033
345 PULMONARY OEDEMA 149 0.0033
346 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 17 0.0033
347 HYPERAESTHESIA 27 0.0033
348 SINUS NODE DYSFUNCTION 6 0.0033
349 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
350 EXTENSOR PLANTAR RESPONSE 3 0.0033
351 TACHYARRHYTHMIA 8 0.0032
352 MYOCLONUS 38 0.0032
353 HEPATIC CONGESTION 3 0.0032
354 DRUG INTERACTION 500 0.0031
355 PARALYSIS 45 0.0031
356 TACHYCARDIA 279 0.0031
357 TYPE I HYPERSENSITIVITY 11 0.0031
358 ATELECTASIS 30 0.0031
359 SINUS BRADYCARDIA 30 0.0031
360 EPIDERMAL NECROSIS 3 0.0031
361 HEPATITIS ACUTE 20 0.0031
362 HYPOTENSION 612 0.0030
363 VOCAL CORD DISORDER 6 0.0030
364 TROPONIN I INCREASED 5 0.0030
365 CARDIOGENIC SHOCK 43 0.0030
366 BRAIN HYPOXIA 3 0.0030
367 RECTAL ABSCESS 5 0.0030
368 POTENTIATING DRUG INTERACTION 10 0.0030
369 BLOOD PRESSURE DECREASED 198 0.0030
370 DYSMORPHISM 7 0.0030
371 OBSTRUCTIVE AIRWAYS DISORDER 33 0.0030
372 HYPERTENSIVE CRISIS 33 0.0030
373 HYPERKALAEMIA 103 0.0029
374 EFFUSION 4 0.0029
375 ISCHAEMIC HEPATITIS 4 0.0029
376 HYPOTONIA 29 0.0029
377 FOETAL EXPOSURE DURING PREGNANCY 236 0.0029
378 PREMATURE BABY 87 0.0029
379 CONSCIOUSNESS FLUCTUATING 3 0.0029
380 HYPOPERFUSION 3 0.0029
381 ALVEOLITIS 4 0.0028
382 TONIC CONVULSION 4 0.0028
383 TRACHEOSTOMY 4 0.0028
384 PNEUMOPERITONEUM 5 0.0027
385 HYPOTHERMIA 27 0.0027
386 DISTRIBUTIVE SHOCK 6 0.0026
387 COAGULOPATHY 44 0.0026
388 PREMATURE DELIVERY 42 0.0026
389 HYPERSENSITIVITY PNEUMONITIS 3 0.0026
390 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
391 BLOODY DISCHARGE 3 0.0026
392 TRAUMATIC LUNG INJURY 5 0.0026
393 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
394 PULMONARY HAEMORRHAGE 20 0.0026
395 HYPORESPONSIVE TO STIMULI 3 0.0026
396 HYPERAEMIA 5 0.0025
397 UNDERWEIGHT 5 0.0025
398 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 24 0.0025
399 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
400 ACUTE HEPATIC FAILURE 34 0.0025
401 STARING 6 0.0025
402 SHOCK 57 0.0025
403 GENERALISED TONIC-CLONIC SEIZURE 40 0.0024
404 CYTOLYTIC HEPATITIS 8 0.0024
405 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
406 WOUND DEHISCENCE 8 0.0024
407 CARDIO-RESPIRATORY ARREST 99 0.0024
408 RESPIRATORY RATE INCREASED 21 0.0024
409 ELECTROCARDIOGRAM QT PROLONGED 85 0.0024
410 HEPATIC CYTOLYSIS 30 0.0024
411 IATROGENIC INJURY 3 0.0023
412 CONGENITAL ANOMALY 18 0.0023
413 UNRESPONSIVE TO STIMULI 60 0.0023
414 VIITH NERVE PARALYSIS 8 0.0023
415 BLOOD CHLORIDE INCREASED 4 0.0023
416 LUNG OPACITY 6 0.0023
417 NEUROLEPTIC MALIGNANT SYNDROME 27 0.0023
418 HYPERTONIA 13 0.0023
419 OLIGURIA 14 0.0023
420 CARDIAC FAILURE ACUTE 15 0.0022
421 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
422 METABOLIC DISORDER 13 0.0022
423 FEAR OF DEATH 5 0.0022
424 RESPIRATORY ARREST 61 0.0022
425 HAEMANGIOMA 5 0.0022
426 METHAEMOGLOBINAEMIA 5 0.0022
427 ECHOCARDIOGRAM ABNORMAL 3 0.0021
428 MULTI-ORGAN FAILURE 37 0.0021
429 BRAIN OEDEMA 27 0.0021
430 OROPHARYNGEAL DISCOMFORT 19 0.0021
431 NEUROLOGICAL SYMPTOM 12 0.0021
432 PNEUMOTHORAX 33 0.0021
433 STILLBIRTH 10 0.0021
434 RALES 12 0.0021
435 EYE MOVEMENT DISORDER 14 0.0020
436 STATUS EPILEPTICUS 23 0.0020
437 CREPITATIONS 6 0.0020
438 VENTRICULAR HYPERTROPHY 5 0.0020
439 DEVICE RELATED SEPSIS 4 0.0020
440 INTRACRANIAL PRESSURE INCREASED 11 0.0020
441 ALANINE AMINOTRANSFERASE INCREASED 117 0.0019
442 DILATATION VENTRICULAR 4 0.0019
443 HYPERPYREXIA 8 0.0019
444 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
445 URINE OUTPUT DECREASED 16 0.0018
446 HEART RATE DECREASED 64 0.0018
447 HYPERVOLAEMIA 9 0.0018
448 HAEMOLYSIS 14 0.0018
449 POST PROCEDURAL HAEMORRHAGE 21 0.0018
450 CAESAREAN SECTION 21 0.0018
451 CARDIOPULMONARY FAILURE 7 0.0018
452 BRAIN INJURY 18 0.0018
453 HEPATORENAL SYNDROME 3 0.0018
454 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
455 RESPIRATORY DISTRESS 49 0.0018
456 HEPATOCELLULAR DAMAGE 4 0.0018
457 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
458 MYOCARDIAL ISCHAEMIA 20 0.0018
459 BLOOD AMYLASE INCREASED 3 0.0018
460 RESPIRATORY FAILURE 127 0.0017
461 ISCHAEMIA 8 0.0017
462 BODY TEMPERATURE INCREASED 35 0.0017
463 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
464 DRUG-INDUCED LIVER INJURY 53 0.0017
465 DEPRESSED LEVEL OF CONSCIOUSNESS 66 0.0017
466 HEPATITIS CHOLESTATIC 10 0.0017
467 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
468 RENAL FAILURE ACUTE 70 0.0016
469 GRAND MAL CONVULSION 15 0.0016
470 MIOSIS 13 0.0016
471 CATHETER PLACEMENT 3 0.0016
472 MONOPLEGIA 7 0.0016
473 CATHETER SITE HAEMORRHAGE 4 0.0016
474 RESPIRATION ABNORMAL 11 0.0016
475 MITRAL VALVE INCOMPETENCE 18 0.0016
476 ACUTE RESPIRATORY DISTRESS SYNDROME 28 0.0016
477 ORTHOPNOEA 5 0.0016
478 CEREBRAL ISCHAEMIA 8 0.0016
479 ENCEPHALOPATHY 38 0.0015
480 EJECTION FRACTION DECREASED 24 0.0015
481 SPINAL CORD COMPRESSION 6 0.0015
482 HYPOVOLAEMIA 9 0.0015
483 HEPATITIS TOXIC 4 0.0015
484 IMMUNE THROMBOCYTOPENIA 7 0.0015
485 DYSKINESIA 62 0.0015
486 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
487 BRADYKINESIA 9 0.0015
488 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
489 COMA 72 0.0015
490 HAEMOPTYSIS 42 0.0015
491 JAUNDICE 40 0.0015
492 BLOOD SODIUM INCREASED 4 0.0015
493 BRADYPNOEA 4 0.0015
494 NORMAL NEWBORN 8 0.0015
495 LEFT VENTRICULAR FAILURE 5 0.0015
496 ACCIDENTAL EXPOSURE 6 0.0014
497 PARKINSONISM 14 0.0014
498 LUNG CONSOLIDATION 4 0.0014
499 HAEMODIALYSIS 12 0.0014
500 RENAL TUBULAR DISORDER 4 0.0014
501 CARDIOVASCULAR DISORDER 36 0.0014
502 BUNDLE BRANCH BLOCK LEFT 6 0.0014
503 FOETAL DISTRESS SYNDROME 3 0.0014
504 ACUTE KIDNEY INJURY 216 0.0014
505 HEPATOCELLULAR INJURY 20 0.0014
506 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
507 POOR PERIPHERAL CIRCULATION 6 0.0014
508 ACUTE RESPIRATORY FAILURE 27 0.0014
509 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
510 HYPERAMMONAEMIA 7 0.0014
511 DRUG TOXICITY 19 0.0014
512 TOXIC SKIN ERUPTION 14 0.0014
513 FACIAL PALSY 3 0.0014
514 MULTIPLE ORGAN DYSFUNCTION SYNDROME 39 0.0014
515 CEREBELLAR SYNDROME 3 0.0014
516 DYSPHEMIA 6 0.0014
517 PARADOXICAL DRUG REACTION 5 0.0014
518 GROWTH RETARDATION 4 0.0014
519 HEMIPARESIS 23 0.0014
520 HEPATIC FAILURE 40 0.0013
521 DELIRIUM 46 0.0013
522 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
523 HYDROCEPHALUS 7 0.0013
524 JAW DISORDER 7 0.0013
525 PREMATURE LABOUR 7 0.0012
526 DEAFNESS NEUROSENSORY 4 0.0012
527 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
528 HEPATIC FIBROSIS 4 0.0012
529 ANGIOEDEMA 51 0.0012
530 CHROMATURIA 26 0.0012
531 EMBOLIC STROKE 4 0.0011
532 JAUNDICE CHOLESTATIC 4 0.0011
533 LUNG INFILTRATION 10 0.0011
534 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
535 AGITATION 83 0.0011
536 EXPOSURE DURING PREGNANCY 70 0.0011
537 ANGIONEUROTIC OEDEMA 3 0.0011
538 BLOOD POTASSIUM ABNORMAL 3 0.0011
539 HEPATOTOXICITY 25 0.0011
540 RENAL TUBULAR NECROSIS 11 0.0011
541 ILEUS PARALYTIC 5 0.0011
542 CONVULSION 64 0.0011
543 SENSORY LOSS 9 0.0011
544 ABDOMINAL RIGIDITY 3 0.0011
545 SHOCK HAEMORRHAGIC 9 0.0011
546 HEART RATE INCREASED 109 0.0011
547 BLOOD PHOSPHORUS INCREASED 3 0.0011
548 INTESTINAL ISCHAEMIA 6 0.0011
549 BLINDNESS TRANSIENT 8 0.0011
550 WOUND HAEMORRHAGE 4 0.0011
551 FEAR 29 0.0011
552 HYPOMAGNESAEMIA 15 0.0011
553 PRE-ECLAMPSIA 5 0.0011
554 CARDIAC TAMPONADE 5 0.0011
555 LACTIC ACIDOSIS 34 0.0010
556 PSEUDOMONAS INFECTION 9 0.0010
557 COMMUNICATION DISORDER 4 0.0010
558 ENTEROCOCCAL INFECTION 5 0.0010
559 ELECTROLYTE IMBALANCE 12 0.0010
560 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
561 ATAXIA 12 0.0010
562 CARDIOTOXICITY 9 0.0010
563 RESPIRATORY DISORDER 30 0.0010
564 CORONARY ARTERY STENOSIS 5 0.0010
565 DRUG TOLERANCE 5 0.0010
566 ASPARTATE AMINOTRANSFERASE INCREASED 52 0.0010
567 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
568 ACUTE CORONARY SYNDROME 8 0.0010
569 FOETAL DEATH 5 0.0010
570 INFUSION SITE EXTRAVASATION 6 0.0010
571 BLOOD BILIRUBIN INCREASED 26 0.0010
572 BLOOD CREATININE DECREASED 3 0.0010
573 LIVE BIRTH 8 0.0010
574 PARTIAL SEIZURES 5 0.0010
575 DRUG EFFECT INCREASED 3 0.0009
576 EYELID OEDEMA 11 0.0009
577 LIP OEDEMA 4 0.0009
578 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
579 INTRAOCULAR PRESSURE INCREASED 12 0.0009
580 HEPATITIS 24 0.0009
581 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
582 ARRHYTHMIA 44 0.0009
583 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
584 PULMONARY FUNCTION TEST DECREASED 4 0.0009
585 RENAL INJURY 27 0.0009
586 ADRENAL INSUFFICIENCY 11 0.0009
587 NO THERAPEUTIC RESPONSE 11 0.0009
588 HYPOALBUMINAEMIA 7 0.0009
589 NECROSIS 5 0.0009
590 FACE OEDEMA 15 0.0009
591 WRONG PRODUCT ADMINISTERED 6 0.0009
592 MOTOR DYSFUNCTION 9 0.0009
593 BLOOD ALBUMIN DECREASED 7 0.0009
594 HEPATIC FUNCTION ABNORMAL 32 0.0009
595 HYPERGLYCAEMIA 31 0.0008
596 EXTRAPYRAMIDAL DISORDER 21 0.0008
597 THERMAL BURN 6 0.0008
598 FIBRIN D DIMER INCREASED 3 0.0008
599 WHEEZING 50 0.0008
600 IMPAIRED WORK ABILITY 18 0.0008
601 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0008
602 PROTHROMBIN TIME PROLONGED 5 0.0008
603 KIDNEY TRANSPLANT REJECTION 4 0.0008
604 PANIC REACTION 6 0.0008
605 GUILLAIN-BARRE SYNDROME 4 0.0008
606 HYPOKINESIA 12 0.0008
607 ASPIRATION 9 0.0008
608 URINARY RETENTION 27 0.0008
609 SCOLIOSIS 5 0.0008
610 NEPHROPATHY TOXIC 9 0.0008
611 HYPOKALAEMIA 37 0.0008
612 FLUID INTAKE REDUCED 4 0.0008
613 TUMOUR LYSIS SYNDROME 7 0.0008
614 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
615 PETIT MAL EPILEPSY 4 0.0008
616 CARDIAC FAILURE 62 0.0008
617 PALLOR 21 0.0008
618 BACTERAEMIA 9 0.0008
619 AZOTAEMIA 3 0.0008
620 CARDIOMYOPATHY 11 0.0007
621 ABORTION INDUCED 7 0.0007
622 ACCIDENTAL OVERDOSE 27 0.0007
623 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
624 HAEMATOMA 19 0.0007
625 EXTRAVASATION 3 0.0007
626 MUSCLE INJURY 6 0.0007
627 HEMIPLEGIA 6 0.0007
628 HEART RATE ABNORMAL 4 0.0007
629 DYSARTHRIA 27 0.0007
630 BLOOD UREA INCREASED 12 0.0007
631 BLOOD CALCIUM DECREASED 8 0.0007
632 BODY TEMPERATURE DECREASED 7 0.0007
633 LYMPHOPENIA 10 0.0007
634 CARDIAC FAILURE CHRONIC 3 0.0007
635 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
636 DRUG RESISTANCE 18 0.0007
637 HYPERTENSION 147 0.0007
638 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
639 RENAL IMPAIRMENT 57 0.0007
640 BLOOD CREATINE INCREASED 3 0.0007
641 HYPERBILIRUBINAEMIA 7 0.0007
642 DEVELOPMENTAL DELAY 6 0.0007
643 DRUG LEVEL INCREASED 11 0.0007
644 DRUG EFFECT DELAYED 3 0.0007
645 FOETAL GROWTH RESTRICTION 4 0.0007
646 RENAL FAILURE 87 0.0007
647 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
648 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
649 LIVER INJURY 16 0.0007
650 MUSCLE TWITCHING 15 0.0007
651 RESTLESSNESS 23 0.0006
652 NEUROTOXICITY 11 0.0006
653 ATRIAL FLUTTER 5 0.0006
654 MOVEMENT DISORDER 20 0.0006
655 MYASTHENIA GRAVIS 5 0.0006
656 CEREBRAL INFARCTION 15 0.0006
657 PHARYNGEAL SWELLING 6 0.0006
658 SPEECH DISORDER 32 0.0006
659 HICCUPS 5 0.0006
660 BREATH SOUNDS ABNORMAL 3 0.0006
661 PULMONARY CONGESTION 8 0.0006
662 HEPATIC ENZYME ABNORMAL 3 0.0006
663 SALIVARY HYPERSECRETION 6 0.0006
664 AGGRESSION 30 0.0006
665 SPLENOMEGALY 7 0.0006
666 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
667 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
668 SUBARACHNOID HAEMORRHAGE 6 0.0006
669 LIVER DISORDER 26 0.0006
670 LUNG INFECTION 9 0.0006
671 ACUTE MYOCARDIAL INFARCTION 17 0.0006
672 PULMONARY HYPERTENSION 12 0.0006
673 CHOLESTASIS 11 0.0006
674 CATATONIA 3 0.0006
675 ANHEDONIA 15 0.0006
676 HAEMORRHAGE 59 0.0006
677 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
678 APHASIA 17 0.0006
679 PNEUMONIA ASPIRATION 14 0.0006
680 EPILEPSY 17 0.0006
681 HAEMATOCRIT DECREASED 11 0.0006
682 BEHAVIOUR DISORDER 3 0.0006
683 TONGUE DISORDER 4 0.0006
684 UNEVALUABLE EVENT 41 0.0005
685 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
686 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
687 HYPOPHOSPHATAEMIA 4 0.0005
688 MEDICAL DEVICE COMPLICATION 4 0.0005
689 TRANSAMINASES INCREASED 12 0.0005
690 BLOOD CREATININE INCREASED 35 0.0005
691 SEDATION 14 0.0005
692 REBOUND EFFECT 6 0.0005
693 SEPTIC SHOCK 23 0.0005
694 TOXICITY TO VARIOUS AGENTS 89 0.0005
695 DRUG ADMINISTRATION ERROR 16 0.0005
696 LIVER FUNCTION TEST ABNORMAL 15 0.0005
697 HEPATOMEGALY 5 0.0005
698 PROCEDURAL PAIN 14 0.0005
699 SEIZURE 58 0.0005
700 OEDEMA 27 0.0005
701 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
702 HYPOGLYCAEMIA 24 0.0005
703 C-REACTIVE PROTEIN INCREASED 18 0.0005
704 DECUBITUS ULCER 4 0.0005
705 PANCREATITIS ACUTE 11 0.0005
706 ILEUS 6 0.0005
707 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
708 PHOTOPHOBIA 9 0.0005
709 DERMATITIS ALLERGIC 6 0.0005
710 INADEQUATE ANALGESIA 4 0.0005
711 FAECES DISCOLOURED 10 0.0005
712 SOMNOLENCE 92 0.0005
713 INJURY 32 0.0005
714 PHARYNGEAL OEDEMA 7 0.0005
715 URTICARIA 76 0.0005
716 ERYTHEMA 93 0.0005
717 DRUG ERUPTION 8 0.0005
718 RASH MACULO-PAPULAR 10 0.0004
719 WRONG DRUG ADMINISTERED 4 0.0004
720 BLOOD PRESSURE INCREASED 68 0.0004
721 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
722 FLUSHING 45 0.0004
723 LEUKOCYTOSIS 8 0.0004
724 PNEUMONIA BACTERIAL 4 0.0004
725 HYPERTRANSAMINASAEMIA 3 0.0004
726 HEPATIC ENCEPHALOPATHY 4 0.0004
727 DIALYSIS 6 0.0004
728 HYPOCALCAEMIA 8 0.0004
729 SPUTUM DISCOLOURED 4 0.0004
730 LOSS OF CONSCIOUSNESS 54 0.0004
731 HYPERLIPIDAEMIA 5 0.0004
732 BLOOD PRESSURE FLUCTUATION 10 0.0004
733 NERVOUS SYSTEM DISORDER 13 0.0004
734 MEDICATION ERROR 23 0.0004
735 FLUID OVERLOAD 6 0.0004
736 PLEURAL EFFUSION 25 0.0004
737 HAEMOGLOBIN DECREASED 42 0.0004
738 ACCIDENTAL EXPOSURE TO PRODUCT 41 0.0004
739 EYELID PTOSIS 4 0.0004
740 HAEMATURIA 13 0.0004
741 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
742 FLATULENCE 21 0.0004
743 PROTEINURIA 7 0.0004
744 MENTAL DISORDER 16 0.0004
745 WOUND INFECTION 4 0.0004
746 CONFUSIONAL STATE 59 0.0004
747 CEREBRAL HAEMORRHAGE 13 0.0004
748 FEELING COLD 10 0.0004
749 CHILLS 42 0.0004
750 ATRIAL SEPTAL DEFECT 3 0.0004
751 OVERDOSE 77 0.0004
752 SWOLLEN TONGUE 11 0.0004
753 HEPATIC ENZYME INCREASED 24 0.0004
754 FACIAL PARALYSIS 3 0.0004
755 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
756 MYOCARDITIS 4 0.0003
757 THROMBOCYTOPENIA 39 0.0003
758 BLOOD MAGNESIUM DECREASED 3 0.0003
759 PRODUCT ADMINISTRATION ERROR 7 0.0003
760 HYPERTHYROIDISM 5 0.0003
761 ATRIAL FIBRILLATION 33 0.0003
762 WITHDRAWAL SYNDROME 14 0.0003
763 BLOOD POTASSIUM DECREASED 10 0.0003
764 SEPSIS 37 0.0003
765 LETHARGY 19 0.0003
766 DEVICE FAILURE 5 0.0003
767 DISORIENTATION 13 0.0003
768 MUSCLE SPASTICITY 4 0.0003
769 CONJUNCTIVITIS 6 0.0003
770 GENERALISED OEDEMA 4 0.0003
771 AGRANULOCYTOSIS 6 0.0003
772 HEPATIC STEATOSIS 6 0.0003
773 BLINDNESS 13 0.0003
774 BLOOD SODIUM DECREASED 6 0.0003
775 PYREXIA 110 0.0003
776 STEVENS-JOHNSON SYNDROME 7 0.0003
777 PRODUCT USE IN UNAPPROVED INDICATION 78 0.0003
778 EMOTIONAL DISTRESS 38 0.0003
779 AFFECT LABILITY 3 0.0003
780 GLAUCOMA 6 0.0003
781 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
782 RASH GENERALISED 8 0.0003
783 MUSCLE TIGHTNESS 5 0.0003
784 PRODUCT USE ISSUE 58 0.0003
785 BEDRIDDEN 4 0.0003
786 CRYING 11 0.0003
787 LEUKOPENIA 15 0.0003
788 CORONARY ARTERY OCCLUSION 4 0.0003
789 HYPERSENSITIVITY 54 0.0003
790 MUSCULAR WEAKNESS 33 0.0003
791 THERAPY NON-RESPONDER 13 0.0003
792 MENTAL IMPAIRMENT 7 0.0003
793 APHONIA 4 0.0003
794 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
795 COGNITIVE DISORDER 13 0.0003
796 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
797 DYSPNOEA 156 0.0003
798 MUSCULOSKELETAL STIFFNESS 24 0.0003
799 RASH ERYTHEMATOUS 13 0.0003
800 MUSCULOSKELETAL DISORDER 5 0.0003
801 OFF LABEL USE 228 0.0003
802 NIGHTMARE 9 0.0003
803 PERICARDIAL EFFUSION 6 0.0003
804 PRESCRIBED OVERDOSE 5 0.0003
805 ASTHMA 29 0.0003
806 LYMPHADENOPATHY 9 0.0003
807 PLATELET COUNT DECREASED 27 0.0003
808 DISABILITY 5 0.0003
809 MENTAL STATUS CHANGES 7 0.0003
810 CHOLECYSTITIS 3 0.0003
811 OROPHARYNGEAL PAIN 23 0.0002
812 HYPERHIDROSIS 32 0.0002
813 DEEP VEIN THROMBOSIS 16 0.0002
814 CARDIOMEGALY 3 0.0002
815 PERITONITIS 5 0.0002
816 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
817 HAEMATEMESIS 6 0.0002
818 TREMOR 39 0.0002
819 CHEST DISCOMFORT 24 0.0002
820 IRRITABILITY 14 0.0002
821 HYPONATRAEMIA 13 0.0002
822 SWELLING FACE 15 0.0002
823 CONDITION AGGRAVATED 70 0.0002
824 LOCAL SWELLING 4 0.0002
825 DRUG INEFFECTIVE 298 0.0002
826 THIRST 4 0.0002
827 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
828 DRUG EFFECT DECREASED 12 0.0002
829 IMPAIRED GASTRIC EMPTYING 3 0.0002
830 VOMITING 103 0.0002
831 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
832 VISUAL IMPAIRMENT 27 0.0002
833 FLUID RETENTION 11 0.0002
834 BLOOD TEST ABNORMAL 3 0.0002
835 IMPAIRED HEALING 7 0.0002
836 BLINDNESS UNILATERAL 3 0.0002
837 FEELING HOT 13 0.0002
838 DYSPHAGIA 20 0.0002
839 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
840 DIABETIC KETOACIDOSIS 5 0.0002
841 PANCREATITIS 11 0.0002
842 ANOSMIA 3 0.0002
843 GASTROENTERITIS 3 0.0002
844 CHEST PAIN 38 0.0002
845 CHOKING 4 0.0002
846 ANAEMIA 39 0.0002
847 PSYCHOTIC DISORDER 6 0.0002
848 PULMONARY EMBOLISM 19 0.0002
849 PREGNANCY 4 0.0002
850 DRY MOUTH 16 0.0002
851 HYPOPHAGIA 5 0.0002
852 PRODUCT PREPARATION ERROR 4 0.0002
853 DIPLOPIA 5 0.0002
854 ANXIETY 54 0.0002
855 MYOCARDIAL INFARCTION 33 0.0002
856 PNEUMONIA 61 0.0002
857 NAUSEA 149 0.0002
858 ABSCESS 3 0.0002
859 SURGERY 11 0.0002
860 RECTAL HAEMORRHAGE 8 0.0002
861 INTERSTITIAL LUNG DISEASE 9 0.0002
862 INTESTINAL OBSTRUCTION 7 0.0002
863 DRUG WITHDRAWAL SYNDROME 16 0.0002
864 STAPHYLOCOCCAL INFECTION 6 0.0002
865 MELAENA 4 0.0002
866 TREATMENT FAILURE 15 0.0002
867 SYNCOPE 18 0.0002
868 MIGRAINE 17 0.0002
869 HEART RATE IRREGULAR 4 0.0002
870 ANGINA PECTORIS 5 0.0002
871 TINNITUS 8 0.0002
872 SKIN DISCOLOURATION 8 0.0002
873 EPISTAXIS 13 0.0002
874 EOSINOPHILIA 3 0.0002
875 ASCITES 5 0.0002
876 GALLBLADDER DISORDER 3 0.0002
877 HYPOAESTHESIA 25 0.0002
878 CARDIAC FAILURE CONGESTIVE 13 0.0002
879 PANCYTOPENIA 9 0.0002
880 VISION BLURRED 22 0.0002
881 HYPOTHYROIDISM 5 0.0002
882 DRUG ABUSE 13 0.0002
883 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
884 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
885 DYSPHONIA 9 0.0002
886 CHOLELITHIASIS 5 0.0002
887 BLOOD PRESSURE ABNORMAL 3 0.0002
888 PRODUCTIVE COUGH 7 0.0001
889 COUGH 41 0.0001
890 RASH 63 0.0001
891 DEVICE MALFUNCTION 10 0.0001
892 MUSCLE SPASMS 26 0.0001
893 EATING DISORDER 3 0.0001
894 RED BLOOD CELL COUNT DECREASED 4 0.0001
895 DEVICE LEAKAGE 6 0.0001
896 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
897 ASTHENIA 51 0.0001
898 LABORATORY TEST ABNORMAL 4 0.0001
899 ADVERSE DRUG REACTION 12 0.0001
900 TREATMENT NONCOMPLIANCE 7 0.0001
901 PAIN 78 0.0001
902 MOOD SWINGS 4 0.0001
903 ABORTION SPONTANEOUS 5 0.0001
904 DEVICE ISSUE 11 0.0001
905 LUNG DISORDER 6 0.0001
906 ABASIA 3 0.0001
907 DEHYDRATION 16 0.0001
908 GAIT INABILITY 4 0.0001
909 HALLUCINATION 9 0.0001
910 CARDIAC DISORDER 11 0.0001
911 GASTRITIS 3 0.0001
912 CEREBROVASCULAR ACCIDENT 19 0.0001
913 THROMBOSIS 9 0.0001
914 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
915 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
916 BRONCHITIS 8 0.0001
917 NECK PAIN 6 0.0001
918 CONSTIPATION 23 0.0001
919 NEUTROPENIA 14 0.0001
920 THERAPEUTIC RESPONSE DECREASED 6 0.0001
921 SUICIDE ATTEMPT 6 0.0001
922 PARAESTHESIA 15 0.0001
923 NO ADVERSE EVENT 17 0.0001
924 RASH PRURITIC 5 0.0001
925 AMNESIA 6 0.0001
926 OEDEMA PERIPHERAL 11 0.0001
927 COLITIS ULCERATIVE 4 0.0001
928 THROAT IRRITATION 4 0.0001
929 GAIT DISTURBANCE 17 0.0001
930 PRURITUS 34 0.0001
931 ABDOMINAL DISTENSION 9 0.0001
932 INCORRECT DOSE ADMINISTERED 19 0.0001
933 ABDOMINAL PAIN 19 0.0001
934 PRODUCT QUALITY ISSUE 11 0.0001
935 BLOOD GLUCOSE INCREASED 15 0.0001
936 CELLULITIS 4 0.0001
937 DIZZINESS 39 0.0001
938 INFLAMMATION 4 0.0001
939 NERVOUSNESS 4 0.0001
940 MUSCULOSKELETAL PAIN 4 0.0001
941 DISEASE PROGRESSION 9 0.0001
942 ABNORMAL BEHAVIOUR 3 0.0001
943 HEADACHE 47 0.0001
944 SWELLING 7 0.0001
945 DISTURBANCE IN ATTENTION 4 0.0001
946 BACK PAIN 17 0.0001
947 COMPLETED SUICIDE 6 0.0001
948 MOBILITY DECREASED 5 0.0001
949 DEATH 59 0.0001
950 STOMATITIS 4 0.0001
951 DISCOMFORT 4 0.0001
952 INJECTION SITE SWELLING 5 0.0001
953 MYALGIA 11 0.0001
954 NEUROPATHY PERIPHERAL 6 0.0001
955 DISEASE RECURRENCE 3 0.0001
956 INTENTIONAL OVERDOSE 4 0.0001
957 DEPRESSION 14 0.0001
958 PALPITATIONS 7 0.0001
959 SKIN EXFOLIATION 5 0.0001
960 BURNING SENSATION 4 0.0001
961 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
962 UNDERDOSE 4 0.0001
963 BLISTER 3 0.0001
964 INSOMNIA 14 0.0001
965 DIABETES MELLITUS 4 0.0001
966 CONTUSION 5 0.0001
967 MALAISE 22 0.0001
968 INFECTION 7 0.0000
969 PRODUCT STORAGE ERROR 4 0.0000
970 INTENTIONAL PRODUCT MISUSE 4 0.0000
971 FEBRILE NEUTROPENIA 3 0.0000
972 PAIN IN EXTREMITY 13 0.0000
973 ADVERSE EVENT 4 0.0000
974 BREAST CANCER 4 0.0000
975 URINARY TRACT INFECTION 7 0.0000
976 DYSGEUSIA 3 0.0000
977 CHRONIC KIDNEY DISEASE 3 0.0000
978 PERIPHERAL SWELLING 6 0.0000
979 ARTHRITIS 3 0.0000
980 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
981 WEIGHT DECREASED 10 0.0000
982 DIARRHOEA 23 0.0000
983 FALL 11 0.0000
984 FATIGUE 24 0.0000
985 DYSPEPSIA 3 0.0000
986 DECREASED APPETITE 7 0.0000
987 ILLNESS 3 0.0000
988 FEELING ABNORMAL 6 0.0000
989 COVID-19 4 0.0000
990 NASOPHARYNGITIS 4 0.0000
991 ALOPECIA 4 0.0000
992 ABDOMINAL PAIN UPPER 4 0.0000
993 DRUG DEPENDENCE 3 0.0000
994 ARTHRALGIA 7 0.0000
995 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000